Virtus ETF Advisers’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-16,790
| Closed | -$57.3K | – | 477 |
|
|
2024
Q3 | $57.3K | Buy |
16,790
+301
| +2% | +$1.03K | 0.03% | 439 |
|
|
2024
Q2 | $77K | Buy |
16,489
+8,499
| +106% | +$39.7K | 0.04% | 421 |
|
|
2024
Q1 | $59.3K | Sell |
7,990
-551
| -6% | -$4.09K | 0.03% | 415 |
|
|
2023
Q4 | $86.5K | Sell |
8,541
-373
| -4% | -$3.78K | 0.05% | 410 |
|
|
2023
Q3 | $69.5K | Sell |
8,914
-891
| -9% | -$6.95K | 0.04% | 387 |
|
|
2023
Q2 | $80.7K | Buy |
9,805
+36
| +0.4% | +$296 | 0.05% | 429 |
|
|
2023
Q1 | $70.8K | Sell |
9,769
-3,751
| -28% | -$27.2K | 0.04% | 402 |
|
|
2022
Q4 | $120K | Buy |
13,520
+3,080
| +30% | +$27.3K | 0.06% | 417 |
|
|
2022
Q3 | $128K | Buy |
10,440
+70
| +0.7% | +$858 | 0.05% | 382 |
|
|
2022
Q2 | $123K | Buy |
10,370
+4,945
| +91% | +$58.7K | 0.05% | 376 |
|
|
2022
Q1 | $103K | Sell |
5,425
-315
| -5% | -$5.98K | 0.05% | 299 |
|
|
2021
Q4 | $152K | Buy |
5,740
+222
| +4% | +$5.88K | 0.06% | 343 |
|
|
2021
Q3 | $227K | Sell |
5,518
-288
| -5% | -$11.8K | 0.1% | 236 |
|
|
2021
Q2 | $329K | Buy |
5,806
+922
| +19% | +$52.2K | 0.14% | 200 |
|
|
2021
Q1 | $205K | Buy |
4,884
+86
| +2% | +$3.61K | 0.09% | 325 |
|
|
2020
Q4 | $336K | Sell |
4,798
-6,619
| -58% | -$464K | 0.14% | 180 |
|
|
2020
Q3 | $320K | Sell |
11,417
-1,570
| -12% | -$44K | 0.17% | 206 |
|
|
2020
Q2 | $384K | Buy |
+12,987
| New | +$384K | 0.18% | 216 |
|